(Q30977623)

27 June 2017

title

Pharmacological peroxisome proliferator-activated receptorgamma ligands: emerging clinical indications beyond diabetes (English)

1 reference

27 June 2017

1 reference

Pershadsingh HA

1

1 reference

27 June 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

Expert Opinion on Investigational Drugs

27 June 2017

published in

1 reference

27 June 2017

volume

8

1 reference

27 June 2017

issue

11

1 reference

27 June 2017

page(s)

1859-1872

1 reference

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Medical significance of peroxisome proliferator-activated receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Orphan nuclear receptors: shifting endocrinology into reverse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Transcription-modulating drugs: a new frontier in the treatment of essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Cardiovascular consequences of polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Antihypertensive effect of pioglitazone is not invariably associated with increased insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Vasodilatory effects of troglitazone improve blood pressure at rest and during mental stress in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Inhibitory action of insulin-sensitizing agents on calcium channels in smooth muscle cells from resistance arteries of guinea-pig

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Hypertension and insulin resistance: role of peroxisome proliferator-activated receptor gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Troglitazone decreases the proportion of small, dense LDL and increases the resistance of LDL to oxidation in obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Effect of troglitazone on fibrinolysis and activated coagulation in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Prognosis of completely asymptomatic adult patients with hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Activation of PPARgamma inhibits cell growth and induces apoptosis in human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Terminal differentiation of human breast cancer through PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Tumor targeting with a selective gelatinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

VEGFs, receptors and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

21 January 2018

Treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Signal transduction pathways in epidermal proliferation and cutaneous inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

All-trans-retinoic acid in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Current use and future potential role of retinoids in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Anti-TNF strategies in Crohn's disease: mechanisms, clinical effects, indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Synovial cytokine and growth factor regulation of MMPs/TIMPs: implications for erosions and angiogenesis in early rheumatoid and psoriatic arthritis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Nitric oxide synthase and cyclooxygenases: distribution, regulation, and intervention in arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Apoptotic cell death in retinal degenerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Adenovirus-mediated delivery of rhodopsin-promoted bcl-2 results in a delay in photoreceptor cell death in the rd/rd mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

Transgenic murine cortical neurons expressing human Bcl-2 exhibit increased resistance to amyloid beta-peptide neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.11.1859

10.1517/13543784.8.11.1859

21 January 2018

Identifiers

DOI

1 reference

27 June 2017

1 reference